505 related articles for article (PubMed ID: 2455193)
1. Effects of antihypertensive drugs on sympathetic vascular control in relation to neuropeptide Y.
Lundberg JM; Pernow J; Franco-Cereceda A; Rudehill A
J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S51-68. PubMed ID: 2455193
[TBL] [Abstract][Full Text] [Related]
2. Non-adrenergic, non-cholinergic vascular control with reference to neuropeptide Y, vasoactive intestinal polypeptide and nitric oxide.
Modin A
Acta Physiol Scand Suppl; 1994; 622():1-74. PubMed ID: 7524267
[TBL] [Abstract][Full Text] [Related]
3. Co-release and functional interactions of neuropeptide Y and noradrenaline in peripheral sympathetic vascular control.
Pernow J
Acta Physiol Scand Suppl; 1988; 568():1-56. PubMed ID: 3232527
[TBL] [Abstract][Full Text] [Related]
4. Modulatory interactions of neuropeptide Y (NPY) on sympathetic neurotransmission.
Linton-Dahlöf P
Acta Physiol Scand Suppl; 1989; 586():1-85. PubMed ID: 2557726
[TBL] [Abstract][Full Text] [Related]
5. Adrenergic and non-adrenergic mechanisms in sympathetic vascular control of the nasal mucosa.
Lacroix JS
Acta Physiol Scand Suppl; 1989; 581():1-63. PubMed ID: 2568728
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide Y Y1 receptor mechanisms in sympathetic vascular control.
Malmström RE
Acta Physiol Scand Suppl; 1997; 636():1-55. PubMed ID: 9179320
[TBL] [Abstract][Full Text] [Related]
7. Sympathetic vascular control of the pig nasal mucosa (III): Co-release of noradrenaline and neuropeptide Y.
Lacroix JS; Stjärne P; Anggärd A; Lundberg JM
Acta Physiol Scand; 1989 Jan; 135(1):17-28. PubMed ID: 2911948
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms underlying pre- and postjunctional effects of neuropeptide Y in sympathetic vascular control.
Pernow J; Saria A; Lundberg JM
Acta Physiol Scand; 1986 Feb; 126(2):239-49. PubMed ID: 3010640
[TBL] [Abstract][Full Text] [Related]
9. Release and vasoconstrictor effects of neuropeptide Y in relation to non-adrenergic sympathetic control of renal blood flow in the pig.
Pernow J; Lundberg JM
Acta Physiol Scand; 1989 Aug; 136(4):507-17. PubMed ID: 2571235
[TBL] [Abstract][Full Text] [Related]
10. [Neuropeptide Y, orthosympathetic nervous system, hypertension and alpha-2 adrenergic receptors].
Poncet MF; Tavernier G; Damase-Michel C; Tran MA; Berlan M; Montastruc JL; Montastruc P
Arch Mal Coeur Vaiss; 1991 Aug; 84(8):1239-41. PubMed ID: 1659347
[TBL] [Abstract][Full Text] [Related]
11. Prejunctional adrenergic receptors and sympathetic neurotransmission: studies in canine skeletal muscle vasculature in situ.
Kahan T
Acta Physiol Scand Suppl; 1987; 560():1-38. PubMed ID: 2884804
[TBL] [Abstract][Full Text] [Related]
12. Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo.
Malmström RE; Lundberg JN; Weitzberg E
Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):106-11. PubMed ID: 11819028
[TBL] [Abstract][Full Text] [Related]
13. Possible involvement of neuropeptide Y in sympathetic vascular control of canine skeletal muscle.
Pernow J; Kahan T; Hjemdahl P; Lundberg JM
Acta Physiol Scand; 1988 Jan; 132(1):43-50. PubMed ID: 2906210
[TBL] [Abstract][Full Text] [Related]
14. Evidence against differential release of noradrenaline, neuropeptide Y, and dopamine-beta-hydroxylase from adrenergic nerves in the isolated perfused sheep spleen.
De Potter WP; Kurzawa R; Miserez B; Coen EP
Synapse; 1995 Feb; 19(2):67-76. PubMed ID: 7725244
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms underlying changes in the contents of neuropeptide Y in cardiovascular nerves and adrenal gland induced by sympatholytic drugs.
Lundberg JM; Saria A; Franco-Cereceda A; Theodorsson-Norheim E
Acta Physiol Scand; 1985 Aug; 124(4):603-11. PubMed ID: 3840321
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide Y is released from human mammary and radial vascular biopsies and is a functional modulator of sympathetic cotransmission.
Donoso MV; Miranda R; Irarrázaval MJ; Huidobro-Toro JP
J Vasc Res; 2004; 41(5):387-99. PubMed ID: 15377822
[TBL] [Abstract][Full Text] [Related]
17. BIBP 3226, suramin and prazosin identify neuropeptide Y, adenosine 5'-triphosphate and noradrenaline as sympathetic cotransmitters in the rat arterial mesenteric bed.
Donoso MV; Steiner M; Huidobro-Toro JP
J Pharmacol Exp Ther; 1997 Aug; 282(2):691-8. PubMed ID: 9262332
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology of noradrenaline and neuropeptide tyrosine (NPY)-mediated sympathetic cotransmission.
Lundberg JM; Franco-Cereceda A; Hemsén A; Lacroix JS; Pernow J
Fundam Clin Pharmacol; 1990; 4(4):373-91. PubMed ID: 2170253
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide Y-induced potentiation of noradrenergic vasoconstriction in the human saphenous vein: involvement of endothelium generated thromboxane.
Fabi F; Argiolas L; Ruvolo G; del Basso P
Br J Pharmacol; 1998 May; 124(1):101-10. PubMed ID: 9630349
[TBL] [Abstract][Full Text] [Related]
20. The neuropeptide Y (NPY) Y1 receptor antagonist BIBP 3226: equal effects on vascular responses to exogenous and endogenous NPY in the pig in vivo.
Malmström RE; Balmér KC; Lundberg JM
Br J Pharmacol; 1997 Jun; 121(3):595-603. PubMed ID: 9179405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]